Gauting, Germany
Ventaleon GmbH is an established player in the Drug Development sector, operating from 29 Robert-Koch-Allee, Gauting, Bavaria, Germany. Founded in 2012, this company is rooted in the Biotechnology, Health Care, and Health and Wellness industries.
Despite its steady course, the firm's last recorded financing was a Venture Round on 01 January 2015, which suggests that it may benefit from renewed capital influx to accelerate its growth agenda. Notably, the investment received backing from prominent names like LSP BioVentures and Abalis Finance, illustrating a level of confidence from well-regarded investors.
Positioned in Germany, Ventaleon GmbH strategically taps into a robust European biotechnology landscape, providing a favorable backdrop for its drug development ambitions. For investors, the company represents an opportunity to re-engage and potentially capitalize on an experienced entity within a competitive sector.
